Literature DB >> 15939304

A new method for purification of recombinant human alpha-synuclein in Escherichia coli.

Chunjuan Huang1, Guoping Ren, Hui Zhou, Chih-chen Wang.   

Abstract

alpha-Synuclein (AS), a major component of Lewy body in Parkinson's disease patients, exists as a natively unfolded protein in physiological buffer. We recently found that the overexpressed AS in Escherichia coli bearing the cloned AS cDNA with no signal sequence was actually located inside the periplasm, but not in the cytoplasm as generally recognized. Therefore, a new protocol for preparing recombinant AS has been developed with only two steps: (1) osmotic shock for release of AS-containing periplasm fraction and (2) ion-exchange chromatography for further purification of AS. By using plasmids and E. coli strains commonly used the new protocol is much more convenient, faster, and cheaper compared to the current methods established since 1994. About 80 mg AS with 95% purity can be regularly prepared from a 1L culture in 3 days.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939304     DOI: 10.1016/j.pep.2005.02.014

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  78 in total

1.  Speeding up sequence specific assignment of IDPs.

Authors:  Wolfgang Bermel; Ivano Bertini; Isabella C Felli; Leonardo Gonnelli; Wiktor Koźmiński; Alessandro Piai; Roberta Pierattelli; Jan Stanek
Journal:  J Biomol NMR       Date:  2012-06-10       Impact factor: 2.835

2.  Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes.

Authors:  Jenifer S Calvo; Neha V Mulpuri; Alex Dao; Nabeeha K Qazi; Gabriele Meloni
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

3.  Translocation of alpha-synuclein expressed in Escherichia coli.

Authors:  Guoping Ren; Xi Wang; Shufeng Hao; Hongyu Hu; Chih-Chen Wang
Journal:  J Bacteriol       Date:  2007-02-02       Impact factor: 3.490

Review 4.  Protein folding in confined and crowded environments.

Authors:  Huan-Xiang Zhou
Journal:  Arch Biochem Biophys       Date:  2007-08-01       Impact factor: 4.013

5.  High-dimensionality 13C direct-detected NMR experiments for the automatic assignment of intrinsically disordered proteins.

Authors:  Wolfgang Bermel; Isabella C Felli; Leonardo Gonnelli; Wiktor Koźmiński; Alessandro Piai; Roberta Pierattelli; Anna Zawadzka-Kazimierczuk
Journal:  J Biomol NMR       Date:  2013-11-08       Impact factor: 2.835

6.  Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein.

Authors:  Theodore A Sarafian; Amneh Yacoub; Anastasia Kunz; Burkan Aranki; Grigor Serobyan; Whitaker Cohn; Julian P Whitelegge; Joseph B Watson
Journal:  J Neurosci Res       Date:  2019-08-16       Impact factor: 4.164

7.  Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitro.

Authors:  Paolo Ruzza; Giuliano Siligardi; Rohanah Hussain; Anna Marchiani; Mehmet Islami; Luigi Bubacco; Giovanna Delogu; Davide Fabbri; Maria A Dettori; Mario Sechi; Nicolino Pala; Ylenia Spissu; Rossana Migheli; Pier A Serra; GianPietro Sechi
Journal:  ACS Chem Neurosci       Date:  2013-10-24       Impact factor: 4.418

Review 8.  In-Cell NMR Spectroscopy of Intrinsically Disordered Proteins.

Authors:  Nicholas Sciolino; David S Burz; Alexander Shekhtman
Journal:  Proteomics       Date:  2019-01-15       Impact factor: 3.984

9.  Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.

Authors:  Vanderlei de Araújo Lima; Lucas Alex do Nascimento; David Eliezer; Cristian Follmer
Journal:  ACS Chem Neurosci       Date:  2018-11-05       Impact factor: 4.418

10.  Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation.

Authors:  Han Cheng; Lei Wang; Chih-chen Wang
Journal:  Cell Stress Chaperones       Date:  2009-12-04       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.